Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
The authors also thank Michael V Sofroniew (University of California Los Angeles) for providing the GFAP-Cre mice, and Shigeyoshi Itohara for providing CaMKII-Cre mice
FEP & PPO Guide
This article explores why a balanced diet is important for people using GLP-1 agonists, the impact of diet on treatment outcomes, and how to be smart when grocery shopping for a healthy diet while taking these medications
CAGRISEMA This GLP-1/amylin-based combination is under investigation & reflects a strategy aimed at enhancing satiety and reducing caloric intake through complementary mechanisms GAME-CHANGERS The broader message for specialists in cardiology, neurology, endocrinology, internal medicine, vascular medicine, and primary care is that obesity treatment is increasingly becoming a cardiometabolic intervention, not only a weight-loss intervention
Co-immunoprecipitation studies demonstrated that the peptide reduces eNOS/caveolin-1 binding by approximately 50%, effectively doubling the available eNOS for nitric oxide production
